Why we shouldn’t rush to administer 3rd doses of coronavirus vaccines

With a great deal of publicity, 2 weeks ago, Israel announced that it was initiating a program to immunize vulnerable Israelis with a 3rd dose of a coronavirus vaccine, a booster shot to re-stimulate the immune system.

It did so because it claims to have data of “waning immunity” in some segments of the population, mostly those with immune deficiency, the very old, and people with certain cancers.

A week after that declaration, however, the Israeli government has just announced that it will not offer these booster shots to cancer patients because after re-analyzing the data, it had found that “Nearly 90 percent of the patients receiving chemotherapy developed antibodies following the (two doses of) vaccination, and the level of antibodies remained high a number of months after the vaccination.”

An important cautionary tale: Governments, doctors, anyone with an agenda should never rush in with a treatment, an intervention, a therapy, anything, until the data collection is as complete as it can get, at least until the next re-analysis.